Nuventra Pharma Sciences is now Allucent. Learn more here.

Take a deeper dive


PBSS Symposium | Cardiac Safety from Preclinical to the Clinic

This event has passed. See all of our upcoming events, browse our Webinar Library for past presentations or, check out our Resource Library for blogs, case studies, news, toolkits and more. 

Registration is now open for PBSS San Francisco’s free online symposium, “Cardiac Safety from Preclinical to the Clinic: Industry and Regulatory Trends in T-QT and Concentration-QT Studies for Assessing QT Prolongation Risks.”

Nuventra’s Associate Director of Clinical Pharmacology,  Lauren R. L. Lohmer, Ph.D., will be presenting on new opportunities for C-QT and C-QT in non-ideal scenarios. In an effort to reduce risk to patients, regulatory agencies now require rigorous analysis of QT intervals in clinical trials as a measure of drug safety.

This seminar will discuss the various ways to evaluate cardiac safety using a variety of methods – as early as preclinical and throughout your clinical trials. Dr. Lohmer will be presenting alongside speakers from ERT Clinical Trial Technology Solutions, Spaulding Clinical, Merck, Terns Pharmaceuticals, and Genentech. This symposium will be offered as a free online webcast and will take place March 23, 2021 – March 24, 2021 | 8:30am – 12:30pm PT.

Event Details

Date & Time: March 23-24 | 8:30am – 12:30pm PT
Location: Online via Zoom
Registration deadline: March 22 (registration will close before if seating cap is reached)